<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-House" bill-type="olc" dms-id="HE8327B1662404EE5B065A19DFC87B4AE" key="H" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 5809 RH: Postoperative Opioid Prevention Act of 2018</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2018-05-15</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">IB</distribution-code>
		<calendar display="yes">Union Calendar No. 586</calendar>
		<congress display="yes">115th CONGRESS</congress><session display="yes">2d Session</session>
		<legis-num display="yes">H. R. 5809</legis-num>
		<associated-doc display="yes" role="report">[Report No. 115–753, Part I]</associated-doc>
		<current-chamber display="yes">IN THE HOUSE OF REPRESENTATIVES</current-chamber>
		<action display="yes">
			<action-date date="20180515">May 15, 2018</action-date>
			<action-desc><sponsor name-id="P000608">Mr. Peters</sponsor> (for himself and <cosponsor name-id="B001275">Mr. Bucshon</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HWM00">Ways and Means</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc>
		</action>
		<action><action-date>June 13, 2018</action-date><action-desc>Additional sponsors: <cosponsor name-id="E000215">Ms. Eshoo</cosponsor>, <cosponsor name-id="B001243">Mrs. Blackburn</cosponsor>, and <cosponsor name-id="W000791">Mr. Walden</cosponsor></action-desc></action><action>
			<action-date>June 13, 2018</action-date>
			<action-desc>Reported from the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name></action-desc>
		</action>
		<action><action-date>June 13, 2018</action-date><action-desc>
				<committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to
			 be printed</action-desc></action><action display="yes">
			<action-desc display="yes"><pagebreak></pagebreak></action-desc>
		</action><legis-type>A BILL</legis-type>
		<official-title display="yes">To amend title XVIII of the Social Security Act to encourage the use of non-opioid analgesics for
			 the management of post-surgical pain under the Medicare program, and for
			 other purposes.<pagebreak></pagebreak></official-title>
	</form>
	<legis-body id="HD9E6FA8A2B5B4430AB36F85111BFBD8C" style="OLC">
 <section id="HC82D45B1D5984E0B849346CFB73B7B6C" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Postoperative Opioid Prevention Act of 2018</short-title></quote>.</text> </section><section id="H0FA9F6851D16461FB1D31D112172FA9C"><enum>2.</enum><header>Medicare incentives for use of non-opioid analgesics in hospital outpatient departments and ambulatory surgical centers</header><text display-inline="no-display-inline">Section 1833(t)(6) of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395l">42 U.S.C. 1395l(t)(6)</external-xref>) is amended—</text>
 <paragraph id="H9C3E2BA9A5C34D549DD0DBB57656252E"><enum>(1)</enum><text>in subparagraph (C)(i), by inserting <quote>or, in the case of an eligible non-opioid analgesic (as defined in subparagraph (J)), during a period of 5 years,</quote> after <quote>3 years,</quote>; and</text>
 </paragraph><paragraph id="H04FAC61CA9814752A2D5D90004C99543"><enum>(2)</enum><text>by adding at the end the following new subparagraph:</text> <quoted-block display-inline="no-display-inline" id="H1F5762C3318C478B8D5164453F957943" style="OLC"> <subparagraph id="H71DE3ACFAA01488F8EAD0E229BFEEDC9"><enum>(J)</enum><header>Eligible non-opioid analgesic defined</header><text display-inline="yes-display-inline">In this paragraph, the term <quote>eligible non-opioid analgesic</quote> means a drug or biological—</text>
 <clause id="H6D0D32994A9943F684688FDDF43816FC"><enum>(i)</enum><text>that is an analgesic that is not an opioid;</text> </clause><clause commented="no" id="H5C271CEEC90E4FFEA475DD8E791F9665"><enum>(ii)</enum><text>that demonstrated substantial clinical improvement; and</text>
 </clause><clause id="H8BEF15B2E0FD49F3848E173D122726E7"><enum>(iii)</enum><text>for which payment—</text> <subclause id="HD26CBCED72AD470E8CFFC27E5DF0C8F1"><enum>(I)</enum><text>as an outpatient hospital service under this part was not being made as of the date of the enactment of this subparagraph; or</text>
 </subclause><subclause id="H28449CD4B1214E6DAC637703D5C32B0E"><enum>(II)</enum><text>was being made under this paragraph as of such date.</text></subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block> </paragraph></section></legis-body> <endorsement display="yes"> <action-date>June 13, 2018</action-date> <action-desc>Reported from the Committee on <committee-name committee-id="HIF00">Energy and Commerce</committee-name></action-desc><action-date>June 13, 2018</action-date><action-desc><committee-name committee-id="HWM00">Committee on Ways and Means</committee-name> discharged; committed to the Committee of the Whole House on the State of the Union and ordered to be printed</action-desc></endorsement> </bill> 

